Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma

Blood (2024) 143 (2): 152–165.

https://doi.org/10.1182/blood.2023021348

Published: 2024

Includes: Supplemental data

Journal Articles

Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma

Kathryn Lurain, Ramya Ramaswami, Eric Oksenhendler, David Boutboul, Alessia Dalla Pria, Lara Ulrich, Krithika Shanmugasundaram, Thomas S. Uldrick, Mark Bower, Robert Yarchoan, Seth M. Steinberg, Laurence Gerard

Blood (2023) 142 (Supplement 1): 985.

https://doi.org/10.1182/blood-2023-179175

Published: 2023

Journal Articles

The Burkitt Lymphoma International Prognostic Index (BL-IPI)

Adam J Olszewski, MD, Lasse H. Jakobsen, PhD, Graham P. Collins, MD DPhil, Kate Cwynarski, Veronika Bachanova, MD PhD, Kristie A. Blum, MD, Kirsten M Boughan, DO, Mark Bower, MD, Alessia Dalla Pria, MD, Alexey Danilov, MD, Kevin A. David, MD, Catherine Diefenbach, MD, Fredrik Ellin, MD PhD, Narendranath Epperla, MDMS, Umar Farooq, MD, Tatyana A. Feldman, MD, Alina S. Gerrie, MD MPH, Deepa Jagadeesh, MDMPH, Manali Kamdar, MD MD, Reem Karmali, MDMSc, Shireen Kassam, MBBS, FRCPath, PhD, Vaishalee P. Kenkre, MD, Nadia Khan, MD, Andreas Klein, MD, Izidore S. Lossos, MD, Matthew A. Lunning, DO, FACP, Peter Martin, FRCPC, MD MS, Nicolas Martinex-Calle, Silvia Montoto, MD, Seema Naik, MD, Neil Palmisiano, MDMS, David Peace, MD, Elizabeth H Phillips, MBBS, BSc, Tycel J. Phillips, MD, Craig A. Portell, MD, Nishitha Reddy, MD, Anna Santarsieri, MBBS, Maryam Sarraf Yazdy, MD, Knut B. Smeland, Scott E. Smith, MD PhD, Stephen D. Smith, MD, Suchitra Sundaram, MD, Parameswaran Venugopal, MD, Adam Zayac, MD, Xiao-Yin Zhang, PhD, Catherine Zhu, Chan Yoon Cheah, MBBS, Tarec Christoffer El-Galaly, Andrew M. Evens, DO,MMSc

Blood (2020) 136 (Supplement 1): 46–49.

https://doi.org/10.1182/blood-2020-134985

Published: 2020

Journal Articles

Prognostication, Survival and Treatment-Related Outcomes in HIV-Associated Burkitt Lymphoma (HIV-BL): A US and UK Collaborative Analysis

Juan Pablo Alderuccio, MD, Adam J Olszewski, MD, Andrew M. Evens, DO,MMSc, Graham P. Collins, MD DPhil, Alexey Danilov, MD, Mark Bower, MD, Deepa Jagadeesh, MDMPH, Catherine Zhu, Amy Sperling, BS, Seo-Hyun Kim, MD, Ryan Vaca, MD, Catherine Wei, Suchitra Sundaram, MD, Nishitha Reddy, MD, Alessia Dalla Pria, MD, Christopher D'Angelo, MD, Umar Farooq, MD, David A. Bond, MD, Stephanie Berg, DO, Michael C. Churnetski, Amandeep Godara, MD, Nadia Khan, MD, Yun Kyong Choi, MD, Shireen Kassam, MBBS, FRCPath, PhD, Maryam Sarraf Yazdy, MD, Emma Rabinovich, MD, Frank Post, Gaurav Varma, MDMPH, Reem Karmali, MDMSc, Madelyn Burkart, MD, Peter Martin, FRCPC, MD MS, Albert Ren, Ayushi Chauhan, MBBS,MD, Catherine Diefenbach, MD, Allandria Straker-Edwards, MS, Andreas Klein, MD, Kristie A. Blum, MD, Kirsten M Boughan, DO, Agrima Mian, MBBS, MD, Bradley Haverkos, MD MPH, MS, Victor M. Orellana-Noia, MD, Vaishalee P. Kenkre, MD, Adam Zayac, MD, Seth M Maliske, MD, Narendranath Epperla, MDMS, Paolo F Caimi, MD, Scott E. Smith, MD PhD, Manali Kamdar, MD, Parameswaran Venugopal, MD, Tatyana A. Feldman, MD, Daniel Rector, Stephen D. Smith, MD, Andrzej Stadnik, MPH, BS, Craig A. Portell, MD, Yong Lin, PhD, Seema Naik, MD, Silvia Montoto, MD, Izidore S. Lossos, MD, Kate Cwynarski

Blood (2020) 136 (Supplement 1): 49–50.

https://doi.org/10.1182/blood-2020-136989

Published: 2020

Journal Articles

Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-134972

Published: 2020

Journal Articles

Serum Proteomics Reveals Distinct Subtypes Associated with Treatment Response in Idiopathic Multicentric Castleman Disease

Blood (2018) 132 (Supplement 1): 3716.

https://doi.org/10.1182/blood-2018-99-119135

Published: 2018

Journal Articles

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients

Alessia Dalla Pria, David Pinato, Jennifer Roe, Kikeri Naresh, Mark Nelson, Mark Bower

Blood (2017) 129 (15): 2143–2147.

https://doi.org/10.1182/blood-2016-10-747477

Published: 2017

Journal Articles

Prognostic Factors in Patients with HIV-Associated Hodgkin Lymphoma: An Analysis of 199 Cases

Michael Furman, MD, Jeremy S. Abramson, MD, Brady E Beltran, MD, Michele Bibas, MD, Mark Bower, MD, Jaime Collins, MD, Joseph M. Connors, MD, Kate Cwynarski, Minh-Li Nguyen, MD, Josep-Maria Ribera, MD, PhD, Paula Y Tanaka, MD, Julie M Vose, MD, MBA, Jorge J Castillo, MD

Blood (2012) 120 (21): 1528.

https://doi.org/10.1182/blood.V120.21.1528.1528

Published: 2012

Journal Articles

HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study

Michael Furman, MD, Pascual Balsalobre, Brady E Beltran, MD, Michele Bibas, MD, Mark Bower, MD, Weina Chen, MD, PhD, Silvia Montoto, MD, Roberto N Miranda, MD, Nahid M. Nanaji, MD, MPH, Jose-Tomas Navarro, MD, Adam C. Seegmiller, MD, PhD, Julie M Vose, MD, Jorge J Castillo, MD

Blood (2011) 118 (21): 1589.

https://doi.org/10.1182/blood.V118.21.1589.1589

Published: 2011

Journal Articles

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era,

Silvia Montoto, MD, Kate Shaw, Jessica Okosun, Shreyans Gandhi, Paul Fields, MD, PhD, Andrew Wilson, Milensu Shanyinde, Kate Cwynarski, Robert E. Marcus, MBBS, FRCP, FRCPath, Johannes de Vos, Anna Marie Young, Melinda Tenant-Flowers, FRCP MSc, Chloe Orkin, Margaret Johnson, Daniella Chilton, John G. Gribben, MD, DSc, Mark Bower, MD

Blood (2011) 118 (21): 3646.

https://doi.org/10.1182/blood.V118.21.3646.3646

Published: 2011

Journal Articles

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

Justin Stebbing, Caroline Adams, Adam Sanitt, Salvinia Mletzko, Mark Nelson, Brian Gazzard, Tom Newsom-Davis, Mark Bower

Blood (2011) 118 (2): 271–275.

https://doi.org/10.1182/blood-2011-02-335620

Published: 2011

Journal Articles

How I treat HIV-associated multicentric Castleman disease

Mark Bower

Blood (2010) 116 (22): 4415–4421.

https://doi.org/10.1182/blood-2010-07-290213

Published: 2010

Journal Articles

Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease

Mark Bower, Ophelia Veraitch, Richard Szydlo, Peter Charles, Peter Kelleher, Brian Gazzard, Mark Nelson, Justin Stebbing

Blood (2009) 113 (19): 4521–4524.

https://doi.org/10.1182/blood-2008-12-197053

Published: 2009

Journal Articles

Excellent Immune Recovery Following the Intensive Chemotherapy CODOX-M/IVAC, An Effective Therapy for HIV-Associated Burkitt’s Lymphoma (BL)

Silvia Montoto, MD, Jamie Wilson, Kate Shaw, Maureen Heath, Andy Wilson, Chloe Orkin, Christopher McNamara, Margaret Johnson, Mark Bower, Kate Cwynarski

Blood (2008) 112 (11): 3612.

https://doi.org/10.1182/blood.V112.11.3612.3612

Published: 2008

Journal Articles

Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma

Mark Bower, Justin Stebbing, Mark Tuthill, Victoria Campbell, Johnathan Krell, Paul Holmes, Andrew Ozzard, Mark Nelson, Brian Gazzard, Tom Powles

Blood (2008) 111 (8): 3986–3990.

https://doi.org/10.1182/blood-2007-10-115659

Published: 2008

Journal Articles

Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease

Tom Powles, Justin Stebbing, Silvia Montoto, Mark Nelson, Brian Gazzard, Chloe Orkin, Andy Webb, Mark Bower

Blood (2007) 110 (12): 4132–4133.

https://doi.org/10.1182/blood-2007-08-106187

Published: 2007

Journal Articles

Opposing roles of dendritic cell subsets in HIV-1 infection

Justin Stebbing, Mark Bower

Blood (2006) 108 (6): 1785–1786.

https://doi.org/10.1182/blood-2006-06-031567

Published: 2006

Journal Articles

The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe

Danish Mazhar, Justin Stebbing, Rachel Lewis, Mark Nelson, Brian G. Gazzard, Mark Bower

Blood (2006) 107 (8): 3412–3414.

https://doi.org/10.1182/blood-2005-08-3119

Published: 2006

Journal Articles

Conservation of unique cell-surface CD antigen mosaics in HIV-1–infected individuals

Adrian Woolfson, Justin Stebbing, Brian D. M. Tom, Kerryn J. Stoner, Walter R. Gilks, David P. Kreil, Stephen P. Mulligan, Larissa Belov, Jeremy S. Chrisp, Will Errington, Adrian Wildfire, Wendy N. Erber, Mark Bower, Brian Gazzard, Richard I. Christopherson, Mike A. Scott

Blood (2005) 106 (3): 1003–1007.

https://doi.org/10.1182/blood-2004-12-4642

Published: 2005

Journal Articles

Protease inhibitors potentiate chemotherapy-induced neutropenia

Mark Bower, Neil McCall-Peat, Natalie Ryan, Liz Davies, Anne Marie Young, Srirupa Gupta, Mark Nelson, Brian Gazzard, Justin Stebbing

Blood (2004) 104 (9): 2943–2946.

https://doi.org/10.1182/blood-2004-05-1747

Published: 2004

NARROW

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma

Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma

The Burkitt Lymphoma International Prognostic Index (BL-IPI)

Prognostication, Survival and Treatment-Related Outcomes in HIV-Associated Burkitt Lymphoma (HIV-BL): A US and UK Collaborative Analysis

Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance

Serum Proteomics Reveals Distinct Subtypes Associated with Treatment Response in Idiopathic Multicentric Castleman Disease

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients

Prognostic Factors in Patients with HIV-Associated Hodgkin Lymphoma: An Analysis of 199 Cases

HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era,

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

How I treat HIV-associated multicentric Castleman disease

Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease

Excellent Immune Recovery Following the Intensive Chemotherapy CODOX-M/IVAC, An Effective Therapy for HIV-Associated Burkitt’s Lymphoma (BL)

Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma

Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease

Opposing roles of dendritic cell subsets in HIV-1 infection

The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe

Conservation of unique cell-surface CD antigen mosaics in HIV-1–infected individuals

Protease inhibitors potentiate chemotherapy-induced neutropenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only